| 產品詳情 |
| Edit |   |
|---|
| Antigenic Specificity | CIP2A |
|---|
| Clone | 2G10 |
|---|
| Host Species | Mouse |
|---|
| Reactive Species | human, mouse, nonhuman primate, rat |
|---|
| Isotype | IgG2b, kappa |
|---|
| Format | DyLight 488 conjugate |
|---|
| Size | 100 μL |
|---|
| Concentration | n/a |
|---|
| Applications | Immunocytochemistry: Assay-Dependent, Immunofluorescence: Assay-Dependent, Western Blot: 0.5-2 μg/mL |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | CIP2A Monoclonal Antibody (2G10), DyLight 488. Inhibition of protein phosphatase 2A (PP2A) activity has been identified as a prerequisite for the transformation of human cells. The protein, designated Cancerous Inhibitor of PP2A (CIP2A), interacts directly with the oncogenic transcription factor c-Myc, inhibits PP2A activity toward c-Myc serine 62 (S62), and thereby prevents c-Myc proteolytic degradation. In addition to its function in c-Myc stabilization, CIP2A promotes anchorage-independent cell growth and in vivo tumor formation. The oncogenic activity of CIP2A is demonstrated by transformation of human cells by overexpression of CIP2A. Importantly, CIP2A is overexpressed in two common human malignancies, head and neck squamous cell carc |
|---|
| Immunogen | n/a |
|---|
| Other Names | CIP2A, p90, cancerous inhibitor of PP2A, p90 autoantigen, protein CIP2A |
|---|
| Gene, Accession # | Entrez: 224171, 57650; Uniprot: Q8BWY9, Q8TCG1 |
|---|
| Catalog # | MA5-16082 |
|---|
| Price | |
|---|
| Order / More Info | CIP2A Antibody from INVITROGEN ANTIBODIES |
|---|
| Product Specific References | n/a |
|---|
| 產品資料 |
|
|